Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)

NCT04554485 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Lymphoblastic Leukemia, Acute, Adult
Ph Negative ALL
Newly Diagnosed

Interventions

DRUG: Blinatumomab

Sponsor

Institute of Hematology and Blood Transfusion, Czech Republic

Collaborators

[object Object]